Industries > Pharma > World Pharma Contract Sales Industry and Market: Predictions 2014-2024

World Pharma Contract Sales Industry and Market: Predictions 2014-2024

PUBLISHED: 06 February 2014
PAGES: 210
PRODUCT CODE:
SUBMARKET: Contract Services

Clear
WOOCS 2.2.1
SKU: N/A Categories: ,

Outsourced selling of medicines – how to find trends, opportunities, and revenue prospects

What's the future of outsourcing pharma sales activities? Now you can get new forecasts for contracted promotional activities for prescription drugs. Stay ahead, then, for data. There you explore business results, developments, trends, opportunities, and predicted revenues.

Visiongain's new report shows you what's possible in those services for pharmaceuticals. Avoid missing out or losing authority. Instead you get financial analysis for that industry and market, discovering outlooks. Find progress in detailing and hear about the expected gains.

Read on to explore that contract healthcare sector, seeing what its future could be worth.

Knowledge to help your work and save time, benefiting your influence

Our study shows you trade predictions to 2024 at overall world, submarket, and national level. For those service offerings you investigate where money lies. Find what's possible.

Ever had trouble getting data you need? Yes, that's frustrating. Instead see how our report helps your research, analyses, and decisions for medical sales. Save time, too, and stay ahead. Also benefit your authority through better understanding the present and future.

Forecasts and other information showing opportunity in that pharmaceutical contracting

Besides forecasting revenues to 2024, that new work shows historical performance, recent results, growth rates, and market shares. There you get feel for companies' outlooks and potentials. You also gain 74 tables, 67 charts, and three interviews with that industry.

And the following sections explain in more detail what you get in the new investigation.

Forecasting of that world market and its main segments – what's likely to happen?

What's that industry's potential? What're the secrets of its progress? Discover in our report overall world revenue to 2024 for contract pharma sales operations.

Also see individual predictions of revenues to 2024 for ten submarkets at world level:
• Cardiovascular disease therapies
• Metabolic disorder treatments
• Cancer-treating agents
• Detailing
• Non-personal promotion.

And get forecasts for these fields and sub-analyses:
• Teledetailing
• Edetailing
• Medical education roles
• Sample management services
• Other related applications.

There you assess outlooks for business, hearing where you can gain. So investigate competition and rising sales. And discover lucrative possibilities there for syndicated pharma sales teams.

That work also shows you geographical predictions.

Healthcare in national markets – outlooks for contracted medical sales

Progress worldwide in healthcare expands use of contracted services for selling and promoting medicines to doctors and other drug prescribers.

You hear about the best revenue prospects for those outsourced and off-shored operations, appraising national opportunities. See where and how you could profit.

Our analyses show you individual revenue forecasts to 2024 for 11 national markets:
• United States (US)
• Japan
• Germany, France, UK, Italy, and Spain (EU5), also with EU regional prediction
• Brazil, Russia, India, and China (BRIC nations).

There you find countries with highest revenues, demands, and potential sales growth. Stay ahead, then, for information. You find international prospects for promoting and selling to medical practitioners.

And what events change that market? Our work shows you, discussing trends and needs.

Developments, challenges, and effects influencing contract sales organisations (CSOs)

The report also explains issues, forces, and events affecting the CSO industry and market from 2014:
• Numbers of contract and in-house sales reps – trends and emerging sales models
• Services CSOs offer and benefits to drug companies outsourcing pharma sales
• Maturing brands and product launches, inc. flexibility in field sales teams
• Physician payment legislation in the US, Europe, and Japan, and new market access requirements for pharma sales representatives – regulatory outlooks
• Changes to online marketing rules for prescription drugs
• Multichannel marketing, key account management (KAM), key opinion leaders (KOLs), and medical science liaison (MSL).

And you explore these influences, among others:
• Smartphones and tablets for new detailing strategies – advances in technology
• Closed loop marketing (CLM), cloud computing, and customer relationship management (CRM), inc. social media use and big data
• Cuts to in-house sales staff – implications for outsourcing service providers
• Strategic partnering and CSO consolidation – networks, links and alliances
• Needs for biological drugs (biologics), biosimilars, and other specialty medicines (with overall world revenue predictions to 2024 for biologics and biosimilars).

There you find what stimulates and restrains players in that industry, and affects its results.

Analysis of companies and potential for market growth – what's possible from 2014?

Our study predicts the world market for pharma contract selling will reach $5.9bn in 2018.

There large pharma service contractors and specialists can profit, expanding business from 2014 to 2024. The new analysis shows you gains possible.

So what happens next? In particular, our report assesses these companies' activities:
• Quintiles
• inVentiv Health
• UDG Healthcare
• PDI
• Publicis Touchpoint Solutions
• OnCall.

There you analyse participants' results, capabilities, and outlooks. You also read three interviews with firms in the industry. Discover what pharma outsourcing providers do, say, and think, helping you stay ahead.

Ways World Pharma Contract Sales Industry and Market: Predictions 2014-2024 helps

Through knowledge such as this, our new report helps you get recognition for insight:
• Revenues there to 2024 at world level, with forecasts for 10 submarkets – assess prospects for investments, marketing, and revenues
• Forecasts to 2024 for 11 national markets in the Americas, Europe, and Asia – investigate developed and developing countries for commercial potentials
• Outlooks for established, rising, and emerging service providers – explore results, capabilities, news, technologies, portfolios, and strategies.

Knowledge found nowhere else, helping your searches, analyses, and plans

Our study gives independent analysis. There you receive competitive intelligence found only in our work, finding where progress and money lie. You explore the commercial possibilities.

So with our data you're less likely to fall behind in knowledge or miss opportunity. Being free to choose, you find with our study how you could save time and effort. Also help your planning, decisions, competing, and authority.

Predictions for outsourced pharma selling – gain by trying our report now

This new report is for everyone investigating medical promotions and selling. There you find revenue forecasting to 2024, with discussions. Avoid missing out – please order it now.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

To view free sample pages of this report please click here

Download sample pages

Complete the form below to download your free sample pages for World Pharma Contract Sales Industry and Market: Predictions 2014-2024


Download sample pages

Complete the form below to download your free sample pages for World Pharma Contract Sales Industry and Market: Predictions 2014-2024


Latest Pharma news

“Global Asthma & COPD market set to grow to $49 bn by 2025” says new Visiongain report

The Asthma and COPD market has the potential to bring several blockbuster drugs to the marketplace due to the increasingly segmented sub-groups of patients.

17 February 2020

READ

“Global Rheumatoid Arthritis Drugs market estimated to grow at a CAGR of 0.6% in the second half of the forecast period” says Visiongain report

Another factor driving the growth in the market is the discovery of new molecules that are involved in the disease process, and hence, new strategies for treating the disease.

17 February 2020

READ

Visiongain assesses that the Contract Research Organisations (CROs) market will generate revenues of $38.0 billion in 2020

Global clinical research organizations market was valued at $34.9 billion in 2019 and is projected to grow at a CAGR of 9.5% during the forecast period 2020-2030.

12 February 2020

READ

“Translational Regenerative Medicine market set to grow to $118bn by 2025” says new Visiongain report

The translational regenerative medicine market is expected to grow significantly due to the advances in technology and improvements in regulatory frameworks.

03 February 2020

READ

Categories

Category